July 13 (Reuters) - Acura Pharmaceuticals Inc ACUR.PK :
* ACURA PHARMACEUTICALS INC - ON JULY 10, 2023, RECEIVED A
$200,000 LOAN FROM ABUSE DETERRENT PHARMA
* ACURA PHARMACEUTICALS INC - FUNDING PROVIDED BY AD PHARMA
WILL
BE USED FOR OPERATIONS THROUGH MID-AUGUST 2023
* ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF
ADDITIONAL
FINANCING BY MID-AUGUST 2023, WE WILL BE REQUIRED TO SCALE BACK
OR TERMINATE OPERATIONS
* ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF
ADDITIONAL
FINANCING BY MID-AUGUST , MIGHT BE REQUIRED TO SEEK PROTECTION
UNDER BANKRUPTCY LAWS
* ACURA PHARMACEUTICALS INC - AT JULY 1, 2023, AD PHARMA
DIRECTLY
OWNS APPROXIMATELY 66% OF OUTSTANDING COMMON STOCK OF COMPANY
Further company coverage: ACUR.PK
((Reuters.Briefs@thomsonreuters.com;))